Skip to main content
Explore URMC

URMC Logo

Angela Glading, Ph.D.

Publications

Showing all 16 journal articles & 0 books available

Journal Articles

2016
DiStefano PV, Smrcka AV, Glading AJ. "Phospholipase C? Modulates Rap1 Activity and the Endothelial Barrier." PloS one. 2016 11(9):e0162338. Epub 2016 Sep 09.

2015
Sarelius IH, Glading AJ. "Control of vascular permeability by adhesion molecules." Tissue barriers. 2015 3(1-2):e985954. Epub 2015 Apr 03.

11/2012
Corr M, Lerman I, Keubel JM, Ronacher L, Misra R, Lund F, Sarelius IH, Glading AJ. "Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo." Arteriosclerosis, thrombosis, and vascular biology.. 2012 Nov 0; 32(11):2702-10. Epub 2012 Aug 23.

2010
Glading AJ, Ginsberg MH. "Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling." Disease models & mechanisms.. 2010 3(1-2):73-83. Epub 2009 Dec 09.

10/22/2007
Glading A, Han J, Stockton RA, Ginsberg MH. "KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions." The Journal of cell biology.. 2007 Oct 22; 179(2):247-54.

2/15/2007
Glading A, Koziol JA, Krueger J, Ginsberg MH. "PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2." Cancer research.. 2007 Feb 15; 67(4):1536-44.

8/2005
Krueger J, Chou FL, Glading A, Schaefer E, Ginsberg MH. "Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation." Molecular biology of the cell.. 2005 Aug 0; 16(8):3552-61. Epub 2005 May 25.

3/2005
Satish L, Blair HC, Glading A, Wells A. "Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain." Molecular and cellular biology.. 2005 Mar 0; 25(5):1922-41.

3/2004
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. "Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation." Molecular and cellular biology.. 2004 Mar 0; 24(6):2499-512.

12/26/2003
Chou FL, Hill JM, Hsieh JC, Pouyssegur J, Brunet A, Glading A, Uberall F, Ramos JW, Werner MH, Ginsberg MH. "PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation." The Journal of biological chemistry.. 2003 Dec 26; 278(52):52587-97. Epub 2003 Sep 23.

4/2002
Shiraha H, Glading A, Chou J, Jia Z, Wells A. "Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain." Molecular and cellular biology.. 2002 Apr 0; 22(8):2716-27.

1/2002
Glading A, Lauffenburger DA, Wells A. "Cutting to the chase: calpain proteases in cell motility." Trends in cell biology. 2002 Jan 0; 12(1):46-54.

6/29/2001
Glading A, Uberall F, Keyse SM, Lauffenburger DA, Wells A. "Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling." The Journal of biological chemistry.. 2001 Jun 29; 276(26):23341-8. Epub 2001 Apr 23.

1/28/2000
Glading A, Chang P, Lauffenburger DA, Wells A. "Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway." The Journal of biological chemistry.. 2000 Jan 28; 275(4):2390-8.

7/12/1999
Shiraha H, Glading A, Gupta K, Wells A. "IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity." The Journal of cell biology.. 1999 Jul 12; 146(1):243-54.

12/1/1998
Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H. "Epidermal growth factor receptor-mediated motility in fibroblasts." Microscopy research and technique.. 1998 Dec 1; 43(5):395-411.